cisplatin

Open Access
The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line
AYAKO OGO, SACHI MIYAKE, HISAKO KUBOTA, MASAHARU HIGASHIDA, HIDEO MATSUMOTO, FUSAKO TERAMOTO, TOSHIHIRO HIRAI and TOMIO UENO

Anticancer Research April 2021, 41 (4) 1771-1778; DOI: https://doi.org/10.21873/anticanres.14942
Open Access
Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer
MOTOYUKI SUZUKI, YUKINORI TAKENAKA, TOSHIHIRO KISHIKAWA, YOSHIFUMI YAMAMOTO, ATSUSHI HANAMOTO, YOICHIRO TOMIYAMA, TAKAHITO FUKUSUMI, TAKAHIRO MICHIBA, NORIHIKO TAKEMOTO, SUSUMU NAKAHARA and HIDENORI INOHARA

Anticancer Research April 2021, 41 (4) 2045-2051; DOI: https://doi.org/10.21873/anticanres.14973
You have access
Acute Kidney Injury Following Hyperthermic Intraperitoneal Chemotherapy With Cisplatin
KERRY L. CHEN, RAPHAEL SHAMAVONIAN, JOSH B. KARPES, NAYEF A. ALZAHRANI and DAVID L. MORRIS

Anticancer Research March 2021, 41 (3) 1641-1646; DOI: https://doi.org/10.21873/anticanres.14926
You have access
Anticancer Efficacy and Mechanism of Amentoflavone for Sensitizing Oral Squamous Cell Carcinoma to Cisplatin
CHENG-HSIEN CHEN, YI-CHI HUANG, YUAN-HAO LEE, ZHAO-LIN TAN, CHIA-JUNG TSAI, YAO-CHEN CHUANG, HSI-FENG TU, TA-CHIH LIU and FEI-TING HSU

Anticancer Research December 2020, 40 (12) 6723-6732; DOI: https://doi.org/10.21873/anticanres.14695
You have access
Protein Profiling of Extracellular Vesicles Associated With Cisplatin Resistance in Lung Cancer
HELIER BALBINOTTI, NATHAN A. CADORE, CRISTINE S. DUTRA, EDILEUZA D. DA SILVA, HENRIQUE B. FERREIRA, ARNALDO ZAHA and KARINA M. MONTEIRO

Anticancer Research October 2020, 40 (10) 5509-5516; DOI: https://doi.org/10.21873/anticanres.14563
You have access
High Expression of p21 as a Potential Therapeutic Target in Ovarian Clear-cell Carcinoma
YUKI MINAGAWA, KOUSUKE ISHINO, RYUICHI WADA, MITSUHIRO KUDO, ZENYA NAITO, TOSHIYUKI TAKESHITA and RYUJI OHASHI

Anticancer Research October 2020, 40 (10) 5631-5639; DOI: https://doi.org/10.21873/anticanres.14576
You have access
Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX
JEAN-DAVID FUMET, JULIE VINCENT, LEILA BENGRINE, AUDREY HENNEQUIN, LAURA GRANCONATO, REMI PALMIER and FRANÇOIS GHIRINGHELLI

Anticancer Research July 2020, 40 (7) 4011-4015; DOI: https://doi.org/10.21873/anticanres.14395
You have access
Characteristics of Gastric Carcinomas With High ERCC1 Expression and the Prognostic Value of ERCC1 Expression
JUNG WOOK YANG, JEONG-HEE LEE, JONG SIL LEE, DONG CHUL KIM, DAE HYUN SONG, SE MIN JANG, HYO JUNG AN, HYUN MIN KOH, MINHYE KIM, JI MIN NA, SANG-HO JEONG, YOUNG-JOON LEE and GYUNG HYUCK KO

Anticancer Research June 2020, 40 (6) 3203-3208; DOI: https://doi.org/10.21873/anticanres.14301
You have access
Clinical Significance of Jagged-1 Activated by APEX1 as a Chemoresistance Factor in Advanced Gastric Cancer
HONG-BEUM KIM, HEE-JEONG LEE, GEE-BEUM KIM, HYUN-JONG LIM, JUN HEE PARK and SANG-GON PARK

Anticancer Research April 2020, 40 (4) 1897-1904; DOI: https://doi.org/10.21873/anticanres.14144
You have access
Cigarette Smoke Reduces the Efficacy of Cisplatin in Head and Neck Cancer Cells – Role of ABCG2
FLORIAN SIMON, SABINA SCHWENK-ZIEGER, SVEN BECKER, KRISTIAN UNGER, OLIVIER GIRES and PHILIPP BAUMEISTER

Anticancer Research March 2020, 40 (3) 1277-1284; DOI: https://doi.org/10.21873/anticanres.14069

Main menu

User menu

Search

cisplatin

Pages